Innovative Industrial Properties (IIPR), a leading real estate investment trust (REIT) specializing in regulated cannabis facilities, is actively restructuring its portfolio amidst a mixed operating environment. The company is making headway in re-leasing properties but continues to face new payment defaults from certain tenants, prompting a decisive management response.
Fresh Defaults Emerge as a Headwind
Despite progress in other areas, IIPR recently encountered new financial difficulties with two tenants. In March 2026, The Cannabist Company failed to make its rental payment for a property located in Pennsylvania. This default represents approximately 2.7% of the REIT’s total rental revenue for the full year 2025.
Separately, Battle Green Holdings also ceased payments for a facility in Ohio. This non-payment accounts for an additional 2.9% of the previous year’s income. The company intends to initially cover these shortfalls using previously secured security deposits. Management has concurrently initiated legal proceedings to enforce its claims, a process that could ultimately lead to the repossession of the affected properties.
Resolution Reached in Major Legal Dispute
In a significant development, IIPR confirmed on March 16, 2026, that it has settled its protracted legal dispute with major tenant PharmaCann. The agreement includes monetary compensation for outstanding receivables and stipulates the return of properties in New York, Ohio, and Pennsylvania by the end of May 2026.
Should investors sell immediately? Or is it worth buying Innovative Industrial?
The company has already demonstrated its re-leasing capability by securing new tenants for three former PharmaCann locations in Michigan, Massachusetts, and Illinois. In March 2026 alone, new lease agreements covering a total of 122,000 square feet were finalized. Furthermore, IIPR has successfully established new arrangements in California for space previously occupied by Gold Flora.
Forward Focus: Re-leasing Pipeline and Timeline
Looking ahead, the REIT has preliminary agreements in place with new interested parties for four additional properties formerly leased to 4Front Ventures. These new leases are expected to become effective in the third quarter of 2026, pending the conclusion of the relevant bankruptcy proceedings.
The return of the remaining PharmaCann properties is anticipated by the end of May 2026, for which IIPR is already actively pursuing new tenants. The company’s strategy remains centered on navigating the ongoing sector-wide challenges through a persistent and focused re-leasing initiative.
Ad
Innovative Industrial Stock: Buy or Sell?! New Innovative Industrial Analysis from March 19 delivers the answer:
The latest Innovative Industrial figures speak for themselves: Urgent action needed for Innovative Industrial investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 19.
Innovative Industrial: Buy or sell? Read more here...
